Health ministry considers imposing less fines on drug makers

Published: 2008-10-02 06:58:00

Updated: 2008-10-02 06:58:00

The Ministry of Health, Welfare and Family Affairs said on September 29 it is considering imposing less fines on pharmaceutical firms who are found to fabricate the bioequivalence testing data.

The planned five-fold fines on improper profits of corresponding pharmaceutical manufactures are gro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK